HomeCompareVCDAX vs JNJ

VCDAX vs JNJ: Dividend Comparison 2026

VCDAX yields 0.80% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VCDAX wins by $778.00 in total portfolio value
10 years
VCDAX
VCDAX
● Live price
0.80%
Share price
$185.91
Annual div
$1.48
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$83.88
Full VCDAX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VCDAX vs JNJ

📍 VCDAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCDAXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCDAX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCDAX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCDAX
Annual income on $10K today (after 15% tax)
$67.70/yr
After 10yr DRIP, annual income (after tax)
$71.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $632.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCDAX + JNJ for your $10,000?

VCDAX: 50%JNJ: 50%
100% JNJ50/50100% VCDAX
Portfolio after 10yr
$20.4K
Annual income
$455.83/yr
Blended yield
2.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VCDAX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCDAX buys
0
JNJ buys
0
No recent congressional trades found for VCDAX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCDAXJNJ
Forward yield0.80%3.36%
Annual dividend / share$1.48$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.8K$20.0K
Annual income after 10y$83.88$827.78
Total dividends collected$819.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VCDAX vs JNJ ($10,000, DRIP)

YearVCDAX PortfolioVCDAX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,780$79.65$10,676$355.77+$104.00VCDAX
2$11,614$80.24$11,407$389.39+$207.00VCDAX
3$12,508$80.80$12,198$426.53+$310.00VCDAX
4$13,465$81.32$13,056$467.62+$409.00VCDAX
5$14,490$81.82$13,987$513.12+$503.00VCDAX
6$15,586$82.28$14,998$563.56+$588.00VCDAX
7$16,760$82.72$16,098$619.52+$662.00VCDAX
8$18,016$83.13$17,295$681.69+$721.00VCDAX
9$19,361$83.51$18,599$750.82+$762.00VCDAX
10$20,800$83.88$20,022$827.78+$778.00VCDAX

VCDAX vs JNJ: Complete Analysis 2026

VCDAXStock

This low-cost index fund offers exposure to the consumer discretionary sector of the U.S. equity market, which includes stocks of companies that manufacture products and provide services that consumers consider nonessential, such as retailers, restaurants, and internet and direct marketing retail companies. The fund’s main risk is its narrow scope—it invests solely in consumer discretionary stocks, which tend to be sensitive to economic cycles. An investor should expect high volatility from the fund, which should be considered only as a small portion of an already well-diversified portfolio.

Full VCDAX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VCDAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCDAX vs SCHDVCDAX vs JEPIVCDAX vs OVCDAX vs KOVCDAX vs MAINVCDAX vs ABBVVCDAX vs MRKVCDAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.